Neoadjuvant Immunotherapy of Operable Metastatic Melanoma in Real Life (GCC)

RecruitingOBSERVATIONAL
Enrollment

77

Participants

Timeline

Start Date

March 24, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Melanoma Metastatic
Trial Locations (9)

Unknown

ACTIVE_NOT_RECRUITING

CHU Angers, Angers

RECRUITING

CHU de Besançon, Besançon

ACTIVE_NOT_RECRUITING

Hôpital Avicenne, Bobigny

ACTIVE_NOT_RECRUITING

CH de Boulogne-sur-Mer, Boulogne-sur-Mer

ACTIVE_NOT_RECRUITING

CHU Clermont-Ferrand, Clermont-Ferrand

ACTIVE_NOT_RECRUITING

Centre de Lutte Contre le Cancer Léon Bérard, Lyon

ACTIVE_NOT_RECRUITING

ICO René Gauducheau, Saint-Herblain

ACTIVE_NOT_RECRUITING

Institut Universitaire de Cancérologie de Toulouse, Toulouse

ACTIVE_NOT_RECRUITING

CH de Valence, Valence

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER